EndoVascular Treatment With Stent-retriever and/or Thromboaspiration vs. Best Medical Therapy in Acute Ischemic Stroke

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 221 participants.

Also called NCT02216643

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 221 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT02216643
Other papers using this trial's data
  • Thrombectomy for Stroke in the Public Health Care System of Brazil The New England journal of medicine, 2020-06-11 DOI, PubMed 32521133

Courtesy of the U.S. National Library of Medicine.

Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Brazil (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT02216643. Randomized; single masking; primary purpose treatment. Start 2017-02-08 (actual); primary completion 2019-06-30 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
EndoVascular Treatment With Stent-retriever and/or Thromboaspiration vs. Best Medical Therapy in Acute Ischemic Stroke
Acronym
RESILIENT
Condition
Stroke
Intervention (Procedure)
Thrombectomy
Intervention (Device)
Stentriever Solitaire FR® or Penumbra System®
Lead sponsor
Hospital de Clinicas de Porto Alegre (class: other)
Collaborator
Ministry of Health, Brazil (class: other government)
Collaborator
Medtronic (class: industry)
Collaborator
Penumbra Inc. (class: industry)
Collaborator
iSchemaView, Inc (class: not stated)
Collaborator
Brainomix Limited (class: industry)

Record details

Record id
cardio:ct-nct02216643
Content hash
0167f1de0ebb4b05f9e04f2832644c6913239cc4f906c17ce50dd6dbbbeb023d